The role of indole metabolites derived from gut microbiota in Parkinson's disease: A comprehensive review
Author:
Top Cited Papers
Open Access
- 10 February 2026
- journal article
- review article
- Published by Elsevier in Brain Research Bulletin
- Vol. 237, 111775
Abstract
No abstract availableKeywords
This publication has 69 references indexed in Scilit:
- Microbial metabolite 3-indolepropionic acid alleviated PD pathologies by decreasing enteric glia cell gliosis via suppressing IL-13Rα1 related signaling pathwaysActa Pharmaceutica Sinica B, 2025
- Gut Microbial Metabolites and Future Risk of Parkinson's Disease: A Metabolome‐Wide Association StudyMovement Disorders, 2024
- Relationship Between Short-chain Fatty Acids and Parkinson’s Disease: A Review from Pathology to ClinicNeuroscience Bulletin, 2023
- Functions of the aryl hydrocarbon receptor (AHR) beyond the canonical AHR/ARNT signaling pathwayBiochemical Pharmacology, 2022
- Microbiota-derived metabolite Indoles induced aryl hydrocarbon receptor activation and inhibited neuroinflammation in APP/PS1 miceBrain, Behavior, and Immunity, 2022
- Appendectomy and risk of Parkinson's disease in two large prospective cohorts of men and womenMovement Disorders, 2018
- Structural changes of gut microbiota in Parkinson’s disease and its correlation with clinical featuresScience China Life Sciences, 2017
- Vagotomy and subsequent risk of Parkinson's diseaseAnnals of Neurology, 2015
- Gut microbiota are related to Parkinson's disease and clinical phenotypeMovement Disorders, 2014
- Is alpha‐synuclein in the colon a biomarker for premotor Parkinson's Disease? Evidence from 3 casesMovement Disorders, 2012